139 related articles for article (PubMed ID: 9090434)
1. Stem cell transplantation: past, present and future.
Thomas ED
Arch Immunol Ther Exp (Warsz); 1997; 45(1):1-5. PubMed ID: 9090434
[TBL] [Abstract][Full Text] [Related]
2. Stem cell transplantation: past, present and future.
Thomas ED
Stem Cells; 1994 Nov; 12(6):539-44. PubMed ID: 7881356
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of hematopoietic progenitor cells with emphasis on the results in children.
Thomas ED
Turk J Pediatr; 1995; 37(1):31-43. PubMed ID: 7732606
[TBL] [Abstract][Full Text] [Related]
4. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract][Full Text] [Related]
5. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
6. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
7. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
Aversa F; Reisner Y; Martelli MF
Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
[TBL] [Abstract][Full Text] [Related]
9. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Managing the toxicity of hematopoietic stem cell transplant.
Pallera AM; Schwartzberg LS
J Support Oncol; 2004; 2(3):223-37; discussion 237-8, 241, 246-7. PubMed ID: 15328824
[TBL] [Abstract][Full Text] [Related]
12. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Pession A; Rondelli R; Paolucci P; Pastore G; Dini G; Bonetti F; Madon E; Mandelli F; Zanesco L; Uderzo C; Prete A; Rabusin M; Ugazio A; Di Bartolomeo P; Favre C; Bojd-Faulkner L; Poggi V; Luksch R; Donfrancesco A; Argiolu F; La Nasa G; Amici A; Locatelli F
Haematologica; 2000 Jun; 85(6):638-46. PubMed ID: 10870122
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood stem cell transplantations: past, present and future.
Hénon PR
Stem Cells; 1993 May; 11(3):154-72. PubMed ID: 8100462
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
17. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
18. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal engraftment after unrelated donor bone marrow and cord blood transplantation.
Davies SM; Radloff GA; Wagner JE; McGlennen R; Kersey JH; Ramsay NK
Biol Blood Marrow Transplant; 1997 Dec; 3(6):304-9. PubMed ID: 9502297
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplantation using peripheral blood stem cells.
Russell NH; Byrne JL
Best Pract Res Clin Haematol; 2001 Dec; 14(4):685-700. PubMed ID: 11924916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]